Lyra Therapeutics Inc (LYRA) — Free Cash Flow Generation Index
Latest as of June 2021:
0.82x
Lyra Therapeutics Inc (LYRA) has a Free Cash Flow Generation Index of 0.82x as of June 2021. Free cash flow of $2.76 Million represents 1% of operating cash flow ($3.38 Million). Explore Lyra Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
0.82x
Free Cash Flow / Operating CF
Free Cash Flow
$2.76 Million
USD
Operating Cash Flow
$3.38 Million
USD
Capital Expenditures
$625.00K
USD
Annual Free Cash Flow Generation for Lyra Therapeutics Inc (None–None)
Year-by-year Free Cash Flow Generation Index for Lyra Therapeutics Inc. Check LYRA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).